Related Experiment Video
Updated: Oct 16, 2026
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
Genetic dissection of cardiac growth control pathways
1Department of Medicine, UCLA School of Medicine 90076, USA.
Abstract:
Cardiac muscle cells exhibit two related but distinct modes of growth that are highly regulated during development and disease. Cardiac myocytes rapidly proliferate during fetal life but exit the cell cycle irreversibly soon after birth, following which the predominant form of growth shifts from hyperplastic to hypertrophic. Much research has focused on identifying the candidate mitogens, hypertrophic agonists, and signaling pathways that mediate these processes in isolated cells. What drives the proliferative growth of embryonic myocardium in vivo and the mechanisms by which adult cardiac myocytes hypertrophy in vivo are less clear. Efforts to answer these questions have benefited from rapid progress made in techniques to manipulate the murine genome. Complementary technologies for gain- and loss-of-function now permit a mutational analysis of these growth control pathways in vivo in the intact heart. These studies have confirmed the importance of suspected pathways, have implicated unexpected pathways as well, and have led to new paradigms for the control of cardiac growth.
Insights
Cardiac muscle cells grow differently before and after birth. Research uses mouse models to understand how cardiac myocyte proliferation and hypertrophy are controlled in the heart.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Molecular Cardiology
Background:
- Cardiac muscle cells (cardiomyocytes) display distinct growth patterns: proliferation in fetal life and hypertrophy post-birth.
- Understanding the in vivo regulation of embryonic cardiomyocyte proliferation and adult cardiomyocyte hypertrophy is crucial for cardiac development and disease.
- Previous research focused on isolated cells, leaving in vivo mechanisms less clear.
Purpose of the Study:
- To elucidate the in vivo mechanisms driving embryonic cardiac myocyte proliferation.
- To investigate the pathways controlling adult cardiac myocyte hypertrophy in vivo.
- To establish new paradigms for cardiac growth control using advanced genetic tools.
Main Methods:
- Utilized rapid advancements in murine genome manipulation techniques.
- Employed complementary gain- and loss-of-function technologies.
- Performed mutational analysis of cardiac growth control pathways in vivo within the intact heart.
Main Results:
- Confirmed the critical roles of previously suspected signaling pathways in cardiac growth.
- Identified novel, unexpected pathways involved in cardiomyocyte proliferation and hypertrophy.
- Provided new insights into the complex regulation of cardiac growth in vivo.
Conclusions:
- In vivo studies using genetic manipulation are essential for understanding cardiac growth regulation.
- Cardiac growth is controlled by a complex interplay of known and novel signaling pathways.
- These findings contribute to new paradigms for controlling cardiac development and disease.
